Description:

SOUTHWEST ONCOLOGY GROUP S0307 ADVERSE EVENT SUMMARY FORM Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DE8CE952-3942-3EB0-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DE8CE952-3942-3EB0-E034-0003BA12F5E7

Keywords:
Versions (4) ▾
  1. 8/26/12
  2. 1/8/15
  3. 1/9/15
  4. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00127205 Toxicity - SOUTHWEST ONCOLOGY GROUP S0307 ADVERSE EVENT SUMMARY FORM - 2286223v3.0

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP S0307 ADVERSE EVENT SUMMARY FORM
    1. No Instruction available.
Header
Adverse Events
Were adverse events assessed during this time period?
CTC Adverse Event Term
CTC Adverse Event Attribution Code (*)
CTC Adverse Event Attribution Code (*)
Comments

Similar models